Plasmafiltration as an effective method in the removal of circulating pegylated liposomal doxorubicin (PLD) and the reduction of mucocutaneous toxicity during the treatment of advanced platinum-resistant ovarian cancer
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11150%2F20%3A10400705" target="_blank" >RIV/00216208:11150/20:10400705 - isvavai.cz</a>
Alternative codes found
RIV/00179906:_____/20:10400705
Result on the web
<a href="https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=2tR0b8PdBb" target="_blank" >https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=2tR0b8PdBb</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1007/s00280-019-03976-2" target="_blank" >10.1007/s00280-019-03976-2</a>
Alternative languages
Result language
angličtina
Original language name
Plasmafiltration as an effective method in the removal of circulating pegylated liposomal doxorubicin (PLD) and the reduction of mucocutaneous toxicity during the treatment of advanced platinum-resistant ovarian cancer
Original language description
The present study evaluates the safety and efficacy of double-plasma filtration (PF) to remove the exceeding pegylated lipposomal doxorubicin (PLD) in ciculation, thus reducing mucocutaneous toxicity. PF can be considered as safe and effective for the extracorporeal removal of PLD, resulting in a lower incidence of mucocutaneous toxicity.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30204 - Oncology
Result continuities
Project
<a href="/en/project/NV16-30366A" target="_blank" >NV16-30366A: Liposoms (drug delivery systems) in kinetically guided therapy of ovarian platinum-resistent carcinoma with doxorubicin using plasmafiltration.</a><br>
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2020
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Cancer Chemotherapy and Pharmacology
ISSN
0344-5704
e-ISSN
—
Volume of the periodical
85
Issue of the periodical within the volume
2
Country of publishing house
DE - GERMANY
Number of pages
13
Pages from-to
353-365
UT code for WoS article
000512980400011
EID of the result in the Scopus database
2-s2.0-85075230002